STAR Pharmaceutical Limited (SGX:AYL) commences share repurchases on August 7, 2018, under the program mandated by the shareholders in the Annual General Meeting held on April 27, 2018. As per the mandate, the company will repurchase up to 4,649,169 shares, representing 10% of its issued capital. In case of on market repurchases, the maximum price that will be paid by the company for repurchases will be 105% of the average closing price over the period of five market days in which transactions in the shares on the SGX-ST were recorded before the day on which such purchase is made. While in case of off-market repurchases, the maximum price that will be paid by the company for repurchases will be 120% of the average closing price over the period of five market days in which transactions in the shares on the SGX-ST were recorded immediately preceding the date of offer by the company. The repurchased shares will either be cancelled or held in treasury. The repurchase will be funded from internal resources and/or external borrowings. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual general Meeting is required to be held or the date on which the authority is carried out to the full extent, unless varied or revoked in a General Meeting.